| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 27.001 | 50.580 | 101.226 | 109.918 | 133.390 | 161.768 |
| Total Income - EUR | - | - | - | - | 27.003 | 52.648 | 101.227 | 109.920 | 133.392 | 164.538 |
| Total Expenses - EUR | - | - | - | - | 20.639 | 42.508 | 59.334 | 64.443 | 71.799 | 94.433 |
| Gross Profit/Loss - EUR | - | - | - | - | 6.364 | 10.140 | 41.894 | 45.477 | 61.593 | 70.105 |
| Net Profit/Loss - EUR | - | - | - | - | 6.094 | 9.783 | 40.931 | 44.477 | 60.419 | 65.833 |
| Employees | - | - | - | - | 2 | 3 | 4 | 3 | 3 | 5 |
Check the financial reports for the company - Mikamed Zolidoc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 13.864 | 30.908 | 24.784 | 19.329 | 38.796 | 64.476 |
| Current Assets | - | - | - | - | 11.585 | 12.149 | 32.056 | 37.931 | 41.583 | 60.424 |
| Inventories | - | - | - | - | 1.541 | 1.270 | 1.242 | 0 | 183 | 0 |
| Receivables | - | - | - | - | 3.430 | 6.086 | 8.258 | 16.767 | 28.157 | 48.730 |
| Cash | - | - | - | - | 6.614 | 4.792 | 22.556 | 21.164 | 13.243 | 11.694 |
| Shareholders Funds | - | - | - | - | 6.136 | 15.802 | 40.972 | 44.523 | 60.570 | 66.257 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 19.313 | 27.255 | 15.869 | 12.737 | 19.808 | 58.643 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Mikamed Zolidoc S.r.l.